301 related articles for article (PubMed ID: 27206758)
1. Oral tranexamic acid (TA) in the treatment of melasma: A retrospective analysis.
Lee HC; Thng TG; Goh CL
J Am Acad Dermatol; 2016 Aug; 75(2):385-92. PubMed ID: 27206758
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of oral tranexamic acid for vitiligo patients with melasma.
Chiang PH; Lin YJ; Chiu YC; Chung WH; Ku CL; Ng CY
Dermatol Ther; 2021 Sep; 34(5):e15047. PubMed ID: 34190390
[TBL] [Abstract][Full Text] [Related]
3. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
[TBL] [Abstract][Full Text] [Related]
4. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.
Del Rosario E; Florez-Pollack S; Zapata L; Hernandez K; Tovar-Garza A; Rodrigues M; Hynan LS; Pandya AG
J Am Acad Dermatol; 2018 Feb; 78(2):363-369. PubMed ID: 28987494
[TBL] [Abstract][Full Text] [Related]
5. Treatment of melasma with oral administration of tranexamic acid.
Wu S; Shi H; Wu H; Yan S; Guo J; Sun Y; Pan L
Aesthetic Plast Surg; 2012 Aug; 36(4):964-70. PubMed ID: 22552446
[TBL] [Abstract][Full Text] [Related]
6. Oral tranexamic acid lightens refractory melasma.
Tan AWM; Sen P; Chua SH; Goh BK
Australas J Dermatol; 2017 Aug; 58(3):e105-e108. PubMed ID: 27173008
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral tranexamic acid on erythema index in patients with melasma.
Nguyen J; Rajgopal Bala H; Ross A; Wong CC; Paul E; Rodrigues M
Australas J Dermatol; 2021 May; 62(2):206-209. PubMed ID: 33125702
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of the combination of tranexamic acid injection and electro-optical synergy (ELOS) versus tranexamic acid injection alone in the treatment of melasma.
Wang Y; Tang L; Duan J; Wang L; Ye F
Lasers Med Sci; 2023 Aug; 38(1):179. PubMed ID: 37552377
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the Efficacy of Tranexamic Acid Solution 5% in the Treatment of Melasma in Patients of South Asian Descent.
Akhtar N; Shah RR; Waqas N; Jasti S; Sharif S; Shah A; Abbasi HH; Rao B
Cutis; 2023 Oct; 112(4):187-191.E4. PubMed ID: 37988305
[TBL] [Abstract][Full Text] [Related]
10. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial.
Kanechorn Na Ayuthaya P; Niumphradit N; Manosroi A; Nakakes A
J Cosmet Laser Ther; 2012 Jun; 14(3):150-4. PubMed ID: 22506692
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic acid in treatment of melasma: A comprehensive review of clinical studies.
Taraz M; Niknam S; Ehsani AH
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133910
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review.
Kim HJ; Moon SH; Cho SH; Lee JD; Kim HS
Acta Derm Venereol; 2017 Jul; 97(7):776-781. PubMed ID: 28374042
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of topical versus intradermal injection of Tranexamic Acid In Egyptian melasma Patients: A randomised clinical trial.
Badran AY; Ali AU; Gomaa AS
Australas J Dermatol; 2021 Aug; 62(3):e373-e379. PubMed ID: 33782959
[TBL] [Abstract][Full Text] [Related]
14. Tranexamic Acid in the Treatment of Melasma: A Review of the Literature.
Perper M; Eber AE; Fayne R; Verne SH; Magno RJ; Cervantes J; ALharbi M; ALOmair I; Alfuraih A; Nouri K
Am J Clin Dermatol; 2017 Jun; 18(3):373-381. PubMed ID: 28283893
[TBL] [Abstract][Full Text] [Related]
15. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
[TBL] [Abstract][Full Text] [Related]
17. Comparison of clinical results of oral tranexamic acid and platelet rich plasma therapies in melasma treatment.
Polat Y; Saraç G
Dermatol Ther; 2022 Jul; 35(7):e15499. PubMed ID: 35395121
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the effect of different doses of oral tranexamic acid on melasma: a multicentre prospective study.
Zhu CY; Li Y; Sun QN; Takada A; Kawada A
Eur J Dermatol; 2019 Feb; 29(1):55-58. PubMed ID: 30734717
[TBL] [Abstract][Full Text] [Related]
19. Oral tranexamic acid for the treatment of melasma.
Ali FR
Clin Exp Dermatol; 2019 Apr; 44(3):347-349. PubMed ID: 30484898
[No Abstract] [Full Text] [Related]
20. Oral tranexamic acid for the treatment of melasma.
Karn D; Kc S; Amatya A; Razouria EA; Timalsina M
Kathmandu Univ Med J (KUMJ); 2012; 10(40):40-3. PubMed ID: 23575051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
